Skip to main content

and
  1. No Access

    Article

    Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy

    Disease relapse occurs in 50% or more of patients who are autografted for relapsed or refractory lymphoma (NHL) or Hodgkin's disease (HD). The administration of non-cross-resistant therapies during the post-tr...

    AP Rapoport, B Meisenberg, C Sarkodee-Adoo, A Fassas in Bone Marrow Transplantation (2002)

  2. No Access

    Article

    Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex

    Unmanipulated autologous bone marrow transplant (ABMT) offers patients with chronic myelogenous leukemia (CML) a long-term survival of 10%, at best. Immunotherapy has a role in the myeloid leukemias, and there...

    JM Rowe, AP Rapoport, DH Ryan, BI Nilsson, RE Duerst in Bone Marrow Transplantation (1999)

  3. No Access

    Article

    Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants

    Unrelated donor marrow transplantation is associated with an increased incidence of graft-versus-host disease (GVHD) compared with sibling donor transplants. Forty-one patients undergoing unrelated donor trans...

    JL Liesveld, RE Duerst, AP Rapoport, LS Constine, CN Abboud in Bone Marrow Transplantation (1999)

  4. No Access

    Article

    Autotransplantation for relapsed or refractory Hodgkin’s disease: long-term follow-up and analysis of prognostic factors

    Seventy consecutive patients with refractory or relapsed Hodgkin’s disease who received high-dose chemotherapy followed by autologous stem cell rescue were analyzed to identify clinically relevant predictors o...

    JE Lancet, AP Rapoport, R Brasacchio, S Eberly, RF Raubertas in Bone Marrow Transplantation (1998)

  5. No Access

    Article

    Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors

    One hundred and thirty-six patients autografted for relapsed or refractory non-Hodgkin’s lymphoma (NHL) were evaluated to assess long-term event-free survival and to identify important prognostic factors. High...

    AP Rapoport, R Lifton, LS Constine, RE Duerst, CN Abboud in Bone Marrow Transplantation (1997)